Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

BACKGROUND: Breast cancer remains a major health problem worldwide, and is becoming increasingly resistant to traditional drug treatments. For instance, Adriamycin (ADR) is beneficial for the treatment of breast cancer. However, its wide application often leads to drug resistance in clinic practice,...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ye, Ding, Jie, Lin, Yan, Li, Juan, Shi, Yongguo, Wang, Juan, Zhu, Ya, Wang, Keming, Hu, Xuezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486132/
https://www.ncbi.nlm.nih.gov/pubmed/26066793
http://dx.doi.org/10.1186/s12906-015-0710-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486132/
https://www.ncbi.nlm.nih.gov/pubmed/26066793
http://dx.doi.org/10.1186/s12906-015-0710-8

Ejemplares similares